Search This Blog

Friday, August 28, 2026

Arcturus, Moderna down on BioNTech trial setback

 Arcturus (ARCT), Moderna (MRNA), and Merck (MRK) fall after a mid-stage trial setback for a cancer shot developed by BioNTech (BNTX) 

https://seekingalpha.com/news/4637973-arcturus-moderna-down-biontech-trial-setback

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.